| Dr Xue Wang, MD | |
|
126 College St, Battle Creek, MI 49037-3461 | |
| (269) 969-6000 | |
| (269) 963-1522 |
| Full Name | Dr Xue Wang |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 126 College St, Battle Creek, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043243959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301088016 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Borgess Medical Center | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Promed | 7315856077 | 233 |
News Archive
Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates against a conventionally challenging target family.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
Febrile illness – the manifestation of a high fever – can be problematic for healthcare providers who, in their search to identify the cause, cannot always tell whether a patient is suffering from a bacterial or viral infection.
Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report.
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
› Verified 3 days ago
| Entity Name | Ascension Medical Group Promed |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497709869 PECOS PAC ID: 7315856077 Enrollment ID: O20031216000478 |
News Archive
Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates against a conventionally challenging target family.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
Febrile illness – the manifestation of a high fever – can be problematic for healthcare providers who, in their search to identify the cause, cannot always tell whether a patient is suffering from a bacterial or viral infection.
Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report.
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
› Verified 3 days ago
| Entity Name | Hometown Urgent Care Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790030385 PECOS PAC ID: 8123270840 Enrollment ID: O20121204000095 |
News Archive
Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates against a conventionally challenging target family.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
Febrile illness – the manifestation of a high fever – can be problematic for healthcare providers who, in their search to identify the cause, cannot always tell whether a patient is suffering from a bacterial or viral infection.
Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report.
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Xue Wang, MD 5943 Stadium Dr, Ste 1, Kalamazoo, MI 49009-3016 Ph: (269) 552-2836 | Dr Xue Wang, MD 126 College St, Battle Creek, MI 49037-3461 Ph: (269) 969-6000 |
News Archive
Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates against a conventionally challenging target family.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
Febrile illness – the manifestation of a high fever – can be problematic for healthcare providers who, in their search to identify the cause, cannot always tell whether a patient is suffering from a bacterial or viral infection.
Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report.
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
› Verified 3 days ago
Dr. Nicole S Boxer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 181 W Emmett St, Battle Creek, MI 49037 Phone: 269-441-3403 Fax: 269-441-1265 | |
Dr. Bruce Weber Galonsky, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont Street, Suite 203, Battle Creek, MI 49017 Phone: 269-969-6123 Fax: 269-969-6122 | |
Gianna L Service, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 485 Columbia Ave E, Suite 11a, Battle Creek, MI 49014 Phone: 269-245-5430 Fax: 269-969-6049 | |
Mr. Wendell L. Diggs, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 363 Fremont St, Ste 203, Battle Creek, MI 49017 Phone: 269-969-6123 Fax: 269-969-6122 | |
Stephen Fedele, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 N 20th St, 20th St Clinic Pc, Battle Creek, MI 49015 Phone: 269-969-6010 Fax: 269-964-8422 | |
Dr. Thomas J. Farchone, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14231 Beadle Lake Rd, Battle Creek, MI 49014 Phone: 269-962-0441 Fax: 269-962-0925 |